Softomotive: Empowering Citizen Developers in Japan, South Korea and China Master RPA
16.12.2019 09:00:00 EET | Business Wire | Press release
Softomotive, the fastest growing Robotic Process Automation (RPA) provider trusted by over 9000 clients globally, announces the localization of its comprehensive free online RPA training to meet the increasing demand of Softomotive’s RPA solutions across 3 new markets: Japan, South Korea and Greater China.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191215005029/en/
Softomotive expands Free online RPA training to 3 new markets: Japan, South Korea and Greater China. (Photo: Business Wire)
Together with the English version, Softomotive’s courses in RPA are now available in Japanese, Mandarin and Korean, with more local versions to come. WinAutomation users in Asia can now benefit from a more tailored experience and master RPA skills through the fully localized curriculum including the on-demand video courses, fact-sheets and quizzes.
“With the localized version of Softomotive’s RPA courses we are able to help even more developers and professionals master RPA skills covering Attended and UnAttended Automation.” says Marios Stavropoulos, Co-Founder and CEO for Softomotive. “By providing WinAutomation courses in Korean, Japanese, and Mandarin we are enabling the growth and adoption of RPA, making it much easier for organizations in those regions to train their employees as they seek to deploy and implement RPA”.
Continuing on its mission to improve the employability quotient of professionals and developers, Softomotive began working with channel partners who have both domain and linguistic expertise to improve the quality of the translations.
Several of our customers in South Korea and Japan also commented on the value of having localized courses on WinAutomation. One said that having Korean courses available is extremely helpful in educating employees and helping citizen developers start creating automations for the business much faster.
The official reveal of the localized courses was done in front of clients and partners in a series of events and meetings Seoul (South Korea), Tokyo (Japan) and Bengaluru (India). During these events, Softomotive’s leadership highlighted the role of Asia-Pacific region as one where RPA adoption is expected to see tremendous growth. The successful events and meetings served as a great platform to showcase how Softomotive’s People1st Approach to RPA, a bottom-up approach giving the power of automation to employees, is enabling businesses locally in South Korea, Japan and Greater China respond to the pressures of reduced labor productivity, following the recent regulations on working hours and work styles.
With the latest updates to the Softomotive Academy, learners from Japan, South Korea and China can obtain a Certification and Diploma in Robotic Process Automation.
Join
Entering the world of the Softomotive Academy is the first step to gaining credibility.
The online RPA learning portal provides an intuitive web-based interface that is accessible from any device (including mobile). Professionals can enroll and discover a rich catalogue of video-based RPA tutorials that support on-demand and self-paced learning on Attended and Unattended Automation.
Learn
Automation knowledge is fast becoming an essential skill set in the labor market.
The RPA Academy offers easy-to-follow individual courses helping learners to master RPA skills covering Attended and Unattended automation. Training ranges from a solid foundation on Robotic Desktop Automation (RDA) and enterprise RPA, to the development of complex process automation via scripting, and the advanced management and monitoring of software robots.
Grow
Receiving an Accreditation in Softomotive’s Process Automation solutions, learners become part of a global network of thousands of professionals already helping their respective organizations accelerate their digitization efforts. A Diploma in RPA enables professionals and developers stay ahead of the rest in this exciting industry. Learners can watch RPA courses at any time tailored for specific roles or can fully customize their learning experience based on their personal learning objectives.
Visit the Softomotive Academy to see the RPA courses in Japanese, Korean and Mandarin.
About Softomotive
Softomotive is one of the leading worldwide providers of Robotic Process Automation (RPA) solutions, trusted by more than 9,000 companies worldwide. Both attended and unattended RPA are delivered through powerful, robust RPA technology, from desktop installation to server-based software which is quick to deploy, easy to use and provides the best value for money
WinAutomation is the world’s best Robotic desktop automation (RDA) tool and provides a powerful, robust and easy to use Windows-based platform for building software robots.
ProcessRobot is a leading enterprise RPA platform, including enterprise grade security and controls, with links to best-of-breed AI technologies.
#ProcessRobot #Softomotive #WinAutomation
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191215005029/en/
Contact information
For more information:
Jesus Kallergis
Softomotive Press Office
Email@ press@softomotive.com
Tel: +44 207 048 2000
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom